Form 4: Bluebird Bio Director Richard Paulson Acquires Shares and Options

Director Richard Paulson acquired shares and options in Bluebird Bio on November 6, 2024, as reported in a Form 4 filing.

Summary

• On November 6, 2024, Richard A. Paulson, a director of bluebird bio, Inc., acquired 24,900 shares of common stock at $0.00 per share.
• Paulson also acquired options to purchase 49,850 shares of common stock at an exercise price of $0.44, which vest on the earlier of November 6, 2025, or the date of the next annual meeting of stockholders and expire on November 6, 2034.
• Following these transactions, Paulson directly owns 29,563 shares of bluebird bio, Inc.
• The transactions were reported on Form 4, filed with the SEC on November 8, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares and options suggests confidence, but it's a routine transaction.

Positives

• A director's acquisition of shares and options can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates